Public health
fromAdvocate.com
2 days agoCVS Health denies coverage for breakthrough HIV drug, committing 'clear violation' of ACA
CVS Health will not cover Gilead's HIV-prevention drug lenacapavir (Yeztugo), citing clinical, financial, regulatory factors and its high annual cost.